These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8964649)

  • 1. Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity.
    Carpenter GW; Breeden L; Carr DJ
    Int J Immunopharmacol; 1995 Dec; 17(12):1001-6. PubMed ID: 8964649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor.
    Carr DJ; Carpenter GW
    Neuroimmunomodulation; 1995; 2(1):44-53. PubMed ID: 7614260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen.
    Carpenter GW; Garza HH; Gebhardt BM; Carr DJ
    Brain Behav Immun; 1994 Sep; 8(3):185-203. PubMed ID: 7865891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice.
    Carpenter GW; Carr DJ
    Immunopharmacology; 1995 Mar; 29(2):129-40. PubMed ID: 7775156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity.
    Garza HH; Prakash O; Carr DJ
    Int J Immunopharmacol; 1994 Dec; 16(12):1061-70. PubMed ID: 7705968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol ester effects on splenic lymphocyte composition and cytotoxic T cell activities of SSIN mice: a strain deficient in CD8+ T cells.
    Yoon HL; Singh KP; Ratner S; Reiners JJ
    Carcinogenesis; 1996 Dec; 17(12):2617-24. PubMed ID: 9006097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.
    Scott M; Carr DJ
    J Pharmacol Exp Ther; 1996 Aug; 278(2):980-8. PubMed ID: 8768756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early development of CD8-negative and CD8-positive MHC-unrestricted cytotoxic cells induced by alloantigen inoculation in mice.
    Nishi Y; Hosokawa T; Aoike A; Kawai K; Kamahora T
    Microbiol Immunol; 1990; 34(9):775-85. PubMed ID: 2126592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity.
    Hilburger ME; Adler MW; Rogers TJ; Eisenstein TK
    J Neuroimmunol; 1997 Dec; 80(1-2):106-14. PubMed ID: 9413265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells.
    Maruyama M; Suzuki H; Yamashita N; Yano S
    Transplantation; 1990 Aug; 50(2):272-7. PubMed ID: 1696410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice--II. Altered cell-mediated immunity and tumor resistance.
    Dean JH; Ward EC; Murray MJ; Lauer LD; House RV; Stillman W; Hamilton TA; Adams DO
    Int J Immunopharmacol; 1986; 8(2):189-98. PubMed ID: 3086244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.